Viewing Study NCT06479356


Ignite Creation Date: 2025-12-24 @ 11:32 PM
Ignite Modification Date: 2026-01-07 @ 10:30 AM
Study NCT ID: NCT06479356
Status: RECRUITING
Last Update Posted: 2024-08-21
First Post: 2024-06-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: CD19-targeted CAR T Cells for Relapsed or Refractory (R/R) Large B-cell Lymphoma
Sponsor: Shanghai Ming Ju Biotechnology Co., Ltd.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module